Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.

Mimi C TanH B El-SeragX YuAaron P Thrift

Published in: Alimentary pharmacology & therapeutics (2018)

Use of PPIs and H2RAs among patients with Barrett's oesophagus are associated with lower risk of OAC. Further clinical trials are needed to confirm this possible chemopreventive effect.

Keyphrases

clinical trial
squamous cell carcinoma
locally advanced
phase ii
wild type
case control
open label
rectal cancer